Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders
Author(s) -
Ileana Mateizel,
Niels De Temmerman,
Urielle Ullmann,
G. Cauffman,
Karen Sermon,
H. Van de Velde,
Martine De Rycke,
Ewoud Degreef,
Paul Devroey,
I. Liebærs,
A. Van Steirteghem
Publication year - 2005
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dei345
Subject(s) - embryonic stem cell , biology , induced pluripotent stem cell , inner cell mass , stem cell , embryo , karyotype , cell culture , microbiology and biotechnology , kosr , myotonic dystrophy , germ layer , genetics , andrology , immunology , blastocyst , embryogenesis , chromosome , medicine , gene
Human embryonic stem (hES) cells are pluripotent cells usually derived from the inner cell mass (ICM) of blastocysts. Because of their ability to differentiate into all three embryonic germ layers, hES cells represent an important material for studying developmental biology and cell replacement therapy. hES cell lines derived from blastocysts diagnosed as carrying a genetic disorder after PGD represent in vitro disease models.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom